Industry Insight
Information, Observation & Analysis
This growing field of intervention-based therapeutics promises to enhance patient health and make healthcare more proactive.
Politicization and polarization have made finding credible information online harder than ever.
Specifically designed to blockade the physiologic IgG recycling function of endothelial cell neonatal crystallizable fragment receptor (FcRn), FcRn antagonists represent a new class of monoclonal antibody-based drugs that have been shown to mediate a sharp, dose-dependent reduction in circulation IgG levels.
Addressing patient misconceptions and uncertainty remains important to help get routine adult vaccinations back on schedule.
The U.S. Monkeypox (mpox) public health emergency formally ended in early 2023. Yet, while mpox isn't completely gone, the average number of daily cases has dwindled into the single digits. Still, many questions for public health officials remain.
The effects of exposure to misinformation about vaccines has been exacerbated by the COVID-19 pandemic. And, misinformation continues to flourish with damaging consequences.
Dispelling the myths surrounding this condition can help parents and caregivers support individuals with ASD, as well as clear up stereotypes and misunderstandings often associated with it.
Most human cases of this zoonotic virus are mild, but knowing the signs, symptoms and preventive measures for transmitting this disease remains important for public health.
New legislation promised to increase patient access to critical drug products by lower costs. Will it work?
Research into targeted, effective vaccines for cancer remains ongoing.
Understanding the realities surrounding stress and its impacts on the body and mind can help individuals better manage this growing national health crisis.
Because there is no cure or vaccine for this widespread parasitic infection, knowing how toxoplasmosis is spread and best practices for preventing transmission remains important.